Heart Lung and Circulation, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
European Heart Journal, Journal Year: 2021, Volume and Issue: 42(36), P. 3599 - 3726
Published: June 11, 2021
Language: Английский
Citations
8803
European Heart Journal, Journal Year: 2021, Volume and Issue: 43(7), P. 561 - 632
Published: June 11, 2021
Guidelines •
Language: Английский
Citations
3724
European Journal of Heart Failure, Journal Year: 2022, Volume and Issue: 24(1), P. 4 - 131
Published: Jan. 1, 2022
Language: Английский
Citations
1516
European Journal of Cardio-Thoracic Surgery, Journal Year: 2021, Volume and Issue: 60(4), P. 727 - 800
Published: Aug. 28, 2021
The ESC/EACTS Guidelines represent the views of ESC and EACTS were produced after careful consideration scientific medical knowledge evidence available at time their publication.The are not responsible in event any contradiction, discrepancy and/ or ambiguity between other official recommendations guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals encouraged take fully into account when exercising clinical judgment, as well determination implementation preventive, diagnostic strategies; however, ESC/ do override, way whatsoever, individual responsibility make appropriate accurate decisions each patient's condition consultation with that patient and, where and/or necessary, caregiver.Nor exempt from taking full updated competent order manage case light scientifically accepted data pursuant respective ethical professional obligations.It is also professional's verify applicable rules regulations relating drugs devices prescription.
Language: Английский
Citations
492
Revista Española de Cardiología (English Edition), Journal Year: 2022, Volume and Issue: 75(6), P. 524 - 524
Published: May 27, 2022
Language: Английский
Citations
383
EuroIntervention, Journal Year: 2022, Volume and Issue: 17(14), P. e1126 - e1196
Published: Feb. 1, 2022
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their dating.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use care therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical judgment as well determination implementation preventive, diagnostic strategies.However, do override way whatsoever individual responsibility make appropriate accurate decisions each patient's condition consultation with that patient caregiver where necessary.Nor exempt from taking full updated competent authorities order manage case light scientifically accepted data pursuant respective ethical professional obligations.It also professional's verify applicable rules regulations relating drugs devices prescription.
Language: Английский
Citations
284
Revista Española de Cardiología, Journal Year: 2022, Volume and Issue: 75(6), P. 523.e1 - 523.e114
Published: April 14, 2022
Citations
89
New England Journal of Medicine, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 31, 2024
BackgroundCurrent treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair mitral-valve surgery. Data from randomized trials comparing these therapies are lacking in this patient population.MethodsIn noninferiority trial conducted Germany, who continued to have symptoms despite guideline-directed medical therapy were randomly assigned, a 1:1 ratio, undergo either (intervention group) or surgical replacement (surgery group). The primary efficacy end point was composite of death, hospitalization failure, reintervention, implantation an assist device, stroke within 1 year after the procedure. safety major adverse events 30 days procedure.ResultsA total 210 underwent randomization. mean (±SD) age 70.5±7.9 years, 39.9% women, left ventricular ejection fraction 43.0±11.7%. Within year, at least one components occurred 16 96 available data (16.7%) intervention group 20 89 (22.5%) surgery (estimated difference, −6 percentage points; 95% confidence interval [CI], −17 6; P<0.001 noninferiority). A end-point event 15 101 (14.9%) 51 93 (54.8%) −40 CI, −51 −27; P<0.001).ConclusionsAmong regurgitation, noninferior respect rehospitalization stroke, device ventricle year. (Funded by Abbott Vascular; MATTERHORN ClinicalTrials.gov number, NCT02371512.)
Language: Английский
Citations
38
The Lancet, Journal Year: 2024, Volume and Issue: 403(10436), P. 1576 - 1589
Published: March 27, 2024
Language: Английский
Citations
26
European Heart Journal, Journal Year: 2024, Volume and Issue: 45(11), P. 922 - 936
Published: Jan. 19, 2024
Abstract Background and Aims Risk stratification for mitral valve transcatheter edge-to-edge repair (M-TEER) is paramount in the decision-making process to appropriately select patients with severe secondary regurgitation (SMR). This study sought develop validate an artificial intelligence-derived risk score (EuroSMR score) predict 1-year outcomes (survival or survival + clinical improvement) SMR undergoing M-TEER. Methods An was developed from EuroSMR cohort (4172 428 treated M-TEER derivation validation cohorts, respectively). The validated compared established models. Results score, which based on 18 clinical, echocardiographic, laboratory, medication parameters, allowed improved discrimination of surviving non-surviving (hazard ratio 4.3, 95% confidence interval 3.7–5.0; P < .001), outperformed scores cohort. Prediction mortality (area under curve: 0.789, 0.737–0.842) ranged <5% >70%, including identification extreme-risk population (2.6% entire cohort), had a very high probability not beyond 1 year 6.5, 3.0–14; .001). top 5% highest showed event rates 72.7% 83.2% lack improvement at follow-up. Conclusions may allow prognostication heart failure SMR, who are considered procedure. expected facilitate shared team members patients.
Language: Английский
Citations
22